Effect of the Ultrasound-guided Percutaneous Neuromodulation on the Anterior Pain Knee: a Pilot Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Seville
- Enrollment
- 28
- Locations
- 2
- Primary Endpoint
- range joint
Study Overview
Brief Summary
Anterior knee pain (AKP) is one of the most frequent pathologies of the lower limb, in young and adult subjects. In the field of Physiotherapy, ultrasound-guided Percutaneous Neuromodulation (PNM) is defined as the application through a needle with ultrasound guidance of an electrical current at low or medium frequency, seeking a sensitive and / or motor response of a peripheral nerve in some point of its trajectory, or of a muscle in a motor point, with a therapeutic objective. The objective of this study is to analyze that the effect of PNM on the femoral nerve produces statistically significant changes in pain, joint range and knee functionality in patients with chronic AKP. Thirty subjects will be recruited, which will be divided into 2 groups: group 1 to which PNM will be applied to the femoral nerve of the pain knee; and group 2 to which PNM will be applied to the femoral nerve of the non-pain knee. The PNM intervention with NMP will consist in the single application of an asymmetric rectangular biphasic current (250 microseconds, 10 Hz)
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 50 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •chronic anterior knee pain >3 months
- •older than 18 years-old
Exclusion Criteria
- •Surgical intervention in the intervention area
- •Prosthesis or osteosynthesis in the intervention area
- •Cardiac or tumoral diseases
- •Coagulopathies
- •Be under the effects of certain medications
- •contraindication characteristic of the puncture
Outcomes
Primary Outcomes
range joint
Time Frame: up to 1 week
goniometer
visual analog scale (VAS) (0, no pain; 100, maximum pain).
Time Frame: up to 1 week
pain
Kujala questionnaire (0, maximum pain; 100, no pain).
Time Frame: up to 1 week
Functional pain
VISA-p questionnaire (0, maximum pain; 100, no pain).
Time Frame: up to 1 week
Functional pain
Secondary Outcomes
No secondary outcomes reported
Investigators
Blanca de la Cruz Torres
Director
University of Seville